Cytosorbents (CTSO) Notes Payables (2011 - 2014)

Cytosorbents' Notes Payables history runs 4 years deep, the most recent figure standing at $709338.0 for Q2 2014.

• Quarterly Notes Payables fell 22.23% year-over-year to $709338.0 in Q2 2014, while the trailing twelve-month figure through Jun 2014 was $709338.0 (down 22.23% YoY) and the FY2013 annual result came in at $1.6 million, up 77.53% from the prior year.
• Notes Payables was $709338.0 for Q2 2014 at Cytosorbents, down from $1.7 million in the prior quarter.
• Across five years, Notes Payables topped out at $1.7 million in Q1 2014 and bottomed at $238015.0 in Q3 2011.
• A 4-year average of $1.0 million and a median of $973379.0 in 2012 frame the typical range for Notes Payables.
• Annual changes were most pronounced in 2012 — Notes Payables surged 308.96% — and 2013, when it retreated 23.05%.
• Cytosorbents' Notes Payables stood at $294323.0 in 2011, then soared by 214.7% to $926225.0 in 2012, then jumped by 77.53% to $1.6 million in 2013, then plunged by 56.86% to $709338.0 in 2014.
• Business Quant data shows CTSO's Notes Payables at $709338.0 in Q2 2014, $1.7 million in Q1 2014, and $1.6 million in Q4 2013.